OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aggregation of therapeutic monoclonal antibodies due to thermal and air/liquid interfacial agitation stress: Occurrence, stability assessment strategies, aggregation mechanism, influencing factors, and ways to enhance stability
Shravan Sreenivasan, Christian Schöneich, Anurag S. Rathore
International Journal of Pharmaceutics (2024), pp. 124735-124735
Closed Access | Times Cited: 3
Shravan Sreenivasan, Christian Schöneich, Anurag S. Rathore
International Journal of Pharmaceutics (2024), pp. 124735-124735
Closed Access | Times Cited: 3
Showing 3 citing articles:
Impact of Various Forced Oxidative Stress Factors in Rapid Degradation of mAb: Trastuzumab as a Case Study
Shravan Sreenivasan, Anurag S. Rathore
Pharmaceutical Research (2025) Vol. 42, Iss. 2, pp. 335-351
Closed Access | Times Cited: 1
Shravan Sreenivasan, Anurag S. Rathore
Pharmaceutical Research (2025) Vol. 42, Iss. 2, pp. 335-351
Closed Access | Times Cited: 1
Physical stability of bevacizumab solutions for intravitreal injections: Influence of conditioning material and storage conditions
Joëlle Claves, Philip Chennell, Christelle Blavignac, et al.
International Journal of Pharmaceutics (2025) Vol. 674, pp. 125453-125453
Open Access
Joëlle Claves, Philip Chennell, Christelle Blavignac, et al.
International Journal of Pharmaceutics (2025) Vol. 674, pp. 125453-125453
Open Access
Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies
Merve Celik Yamaci, Ceren Pamukcu, Yiğit Erdemgil, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 579-579
Open Access
Merve Celik Yamaci, Ceren Pamukcu, Yiğit Erdemgil, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 579-579
Open Access
Artificial intelligence in drug development for delirium and Alzheimer’s disease
Ruixue Ai, Xianglu Xiao, Shuling Deng, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Ruixue Ai, Xianglu Xiao, Shuling Deng, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
